Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weijing decoction (also known as Weijing Tang) is a classic Traditional Chinese Medicine (TCM) formula traditionally used to treat lung abscesses and respiratory conditions characterized by heat and phlegm accumulation. The formula typically comprises four primary herbal ingredients: *Phragmites communis* (Reed Rhizome), *Coix lacryma-jobi* (Job's Tears), *Prunus persica* (Peach Kernel), and *Benincasa hispida* (Winter Melon Seed). In modern clinical research, it is being investigated for its potential to reduce the risk of long-term acute exacerbations in patients with bronchiectasis, particularly those colonized with *Pseudomonas aeruginosa*. Its mechanism of action involves clearing pulmonary heat, resolving phlegm, and promoting the discharge of pus, which may help modulate the inflammatory environment in the lungs and improve clinical symptoms in patients with the syndrome of phlegm-heat accumulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Weijing decoction.